Matches in Wikidata for { <http://www.wikidata.org/entity/Q92095250> ?p ?o ?g. }
Showing items 1 to 44 of
44
with 100 items per page.
- Q92095250 description "artículu científicu espublizáu en xunetu de 2019" @default.
- Q92095250 description "im Juli 2019 veröffentlichter wissenschaftlicher Artikel" @default.
- Q92095250 description "scientific article published on 23 July 2019" @default.
- Q92095250 description "wetenschappelijk artikel" @default.
- Q92095250 description "наукова стаття, опублікована 23 липня 2019" @default.
- Q92095250 name "The use of 68Ga-PET/CT PSMA in the staging of primary and suspected recurrent renal cell carcinoma" @default.
- Q92095250 name "The use of 68Ga-PET/CT PSMA in the staging of primary and suspected recurrent renal cell carcinoma" @default.
- Q92095250 type Item @default.
- Q92095250 label "The use of 68Ga-PET/CT PSMA in the staging of primary and suspected recurrent renal cell carcinoma" @default.
- Q92095250 label "The use of 68Ga-PET/CT PSMA in the staging of primary and suspected recurrent renal cell carcinoma" @default.
- Q92095250 prefLabel "The use of 68Ga-PET/CT PSMA in the staging of primary and suspected recurrent renal cell carcinoma" @default.
- Q92095250 prefLabel "The use of 68Ga-PET/CT PSMA in the staging of primary and suspected recurrent renal cell carcinoma" @default.
- Q92095250 P1433 Q92095250-4CF0FF40-6A19-4888-A557-B8B0B54D390B @default.
- Q92095250 P1476 Q92095250-DC20E99D-E7D4-4CC2-8DF6-246F4A97CC04 @default.
- Q92095250 P2093 Q92095250-27DC7736-8916-4433-981F-CB2F2CB7051D @default.
- Q92095250 P2093 Q92095250-4014BCA0-415D-4FA1-8001-5F1334B66B42 @default.
- Q92095250 P2093 Q92095250-DA8BB142-6B39-460A-AE72-06A1C57C9730 @default.
- Q92095250 P304 Q92095250-D25622FA-7706-4744-B30C-F5F5C857969C @default.
- Q92095250 P31 Q92095250-652970D8-0DE4-49F7-A1E0-15577AE36981 @default.
- Q92095250 P356 Q92095250-352ECF59-8B48-4370-816B-2F17E0B1841F @default.
- Q92095250 P433 Q92095250-4F871097-B663-4B1B-AAB8-B7AF942D8E9F @default.
- Q92095250 P478 Q92095250-A035E28D-1B92-4DAB-8500-B442A3EA2E01 @default.
- Q92095250 P50 Q92095250-0E89FE29-23C8-49BA-A192-7889F43459C8 @default.
- Q92095250 P577 Q92095250-DDFE7213-E4DB-4131-A5D0-20B5C48F7B4B @default.
- Q92095250 P698 Q92095250-22E4613D-C3F6-49D5-A652-EAF1165E035C @default.
- Q92095250 P921 Q92095250-475C4E8F-450C-4602-91DC-7BC26865E8FC @default.
- Q92095250 P921 Q92095250-664B24AC-F3B4-4F1C-BD8A-82585D251DE1 @default.
- Q92095250 P356 S00259-019-04432-2 @default.
- Q92095250 P698 31332498 @default.
- Q92095250 P1433 Q15708890 @default.
- Q92095250 P1476 "The use of 68Ga-PET/CT PSMA in the staging of primary and suspected recurrent renal cell carcinoma" @default.
- Q92095250 P2093 "John Yaxley" @default.
- Q92095250 P2093 "Rachel Esler" @default.
- Q92095250 P2093 "Sam Kyle" @default.
- Q92095250 P304 "2280-2288" @default.
- Q92095250 P31 Q13442814 @default.
- Q92095250 P356 "10.1007/S00259-019-04432-2" @default.
- Q92095250 P433 "11" @default.
- Q92095250 P478 "46" @default.
- Q92095250 P50 Q92095243 @default.
- Q92095250 P577 "2019-07-23T00:00:00Z" @default.
- Q92095250 P698 "31332498" @default.
- Q92095250 P921 Q1164529 @default.
- Q92095250 P921 Q18975901 @default.